Sector: MedicalAvant Immunotherapeutics, Inc. (NASDAQ: AVAN)
Headlines
- ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting
Jun 02, 2008 05:24 PM | AVAN, BMY, DNA, GSK, IMCL, INFI
- Pfizer, Avant Report Positive Results In Brain Cancer Vaccine
Jun 02, 2008 11:30 AM | AVAN, PFE
- NASDAQ Technical Picture - Hanging Man Confirmed
May 20, 2008 12:13 AM | ACTS, AMGN, AMTD, AVAN, CHK, CNTF
- NASDAQ Technical Picture - Hanging Man to End Bullish Week
May 19, 2008 01:56 AM | ADI, AEA, ANN, ARO, ARUN, ASPM
- UPDATE: Positive Lilly Cancer Drug Trial Among ASCO Releases
May 15, 2008 10:46 PM | AVAN, AZN, BAY, BMY, DNA, GSK
- Global Investing Roundups - Apr 19 2008 4:21PM
Apr 19, 2008 04:20 PM | AMTD, AVAN, COF, GOOG, LUV, NOK
- CORRECT: =UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 07:56 PM | AVAN, PFE
- CORRECT: =UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 07:56 PM | AVAN, PFE
- CORRECT: UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant 2-
Apr 16, 2008 07:56 PM | AVAN, PFE
- UPDATE: Pfizer In Brain-Cancer Vaccine Deal With Avant
Apr 16, 2008 06:39 PM | AVAN, PFE
- AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics
Sep 29, 2008 08:14 AM | AVAN
- AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23
Sep 18, 2008 04:01 PM | AVAN
- AVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference
Aug 08, 2008 04:17 PM | AVAN
- CORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial Results
Aug 06, 2008 08:46 AM | AVAN
- AVANT Reports Second Quarter and Six Month Financial Results
Aug 06, 2008 08:06 AM | AVAN
- AVANT to Report Second Quarter 2008 Financial Results on August 6, 2008
Aug 04, 2008 01:57 PM | AVAN
- AVANT Announces Vaccine Adjuvant Licenses with 3M
Jun 11, 2008 08:02 AM | AVAN
- AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference
Jun 04, 2008 11:03 AM | AVAN
- NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
Jun 04, 2008 08:12 AM | AVAN
- Market Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in Development, Sets New 1000 MW Target and Prepares for Rapid Expansion!
Jun 03, 2008 08:30 AM | ACOR, AVAN
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AVAN
|
Compare to S&P
|
| YTD |
93.76 %
|
138.58 %
|
| 4 Weeks |
-15.91 %
|
-7.51 %
|
| 12 Weeks |
-17.28 %
|
-11.19 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 8.22 %
|
|
EPS Growth in Last Year: 20.27 %
|
|
Sales Growth in Last Quarter: 1,234.69 %
|
|
Sales Growth in Last Quarter: 94.45 %
|
|
